The Impact of Dr. Satya Vadlamani’s Leadership on Murli Krishna Pharma
26/06/2024
Dr. Satya Vadlamani, CMD of Murli Krishna Pharma Pvt. Ltd. (MKPPL), has reshaped the pharmaceutical landscape in India with her unwavering dedication and strategic acumen. Armed with a degree in…
How Murli Krishna Pharma is Redefining Pharmaceutical Standards in India
03/06/2024
Murli Krishna Pharma Pvt. Ltd. excels in offering a diverse range of Pre-Finished Formulation Intermediates (PFI) and finished dosage forms that adhere to the highest quality standards. The company's…
Murli Krishna Pharma’s Mission to End Anemia’s Grip on Indian Communities
30/05/2024
Anemia is a significant public health challenge in Indian communities, disproportionately affecting women and children. Murli Krishna Pharma's transdermal lotion offers a unique and non-invasive…